MeSH term
Frequency | Condition_Probility | Child, Preschool | 2 | 0.0 |
Humans | 47 | 0.0 |
Female | 25 | 0.0 |
Chromosomes, Human, Pair 11/*genetics | 7 | 2.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
English Abstract | 2 | 0.0 |
Gene Frequency | 2 | 0.0 |
*Loss of Heterozygosity | 6 | 1.0 |
Microsatellite Repeats | 2 | 0.0 |
Chromosomes, Human, Pair 11/genetics | 4 | 1.0 |
Gene Deletion | 3 | 0.0 |
Multiple Endocrine Neoplasia Type 1/*genetics | 12 | 9.0 |
Polymorphism, Genetic | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 29 | 0.0 |
Adult | 13 | 0.0 |
Chromosome Mapping | 20 | 0.0 |
Loss of Heterozygosity | 3 | 0.0 |
Middle Aged | 10 | 0.0 |
Animals | 5 | 0.0 |
Base Sequence | 13 | 0.0 |
DNA Primers | 4 | 0.0 |
*Chromosomes, Human, Pair 11 | 21 | 3.0 |
Exons | 3 | 0.0 |
Genetic Markers | 14 | 0.0 |
Male | 23 | 0.0 |
Neoplasm Proteins/*genetics | 3 | 0.0 |
Polymerase Chain Reaction | 18 | 0.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
*Proto-Oncogene Proteins | 3 | 0.0 |
Adolescent | 4 | 0.0 |
Phenotype | 3 | 0.0 |
Spain | 2 | 0.0 |
DNA Mutational Analysis | 3 | 0.0 |
*Homozygote | 2 | 1.0 |
Mutation, Missense/*genetics | 2 | 1.0 |
Polymorphism, Restriction Fragment Length | 5 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Phosphorylases/*genetics | 5 | 62.0 |
Adenoma/*genetics | 2 | 2.0 |
Aged | 5 | 0.0 |
DNA, Neoplasm/analysis | 3 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Alleles | 4 | 0.0 |
Breast Neoplasms/*genetics/pathology | 4 | 1.0 |
Amino Acid Substitution | 2 | 0.0 |
Haplotypes | 3 | 0.0 |
Multiple Endocrine Neoplasia Type 1/genetics | 2 | 8.0 |
Pedigree | 12 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Chromosomes, Human, Pair 11 | 2 | 0.0 |
Linkage (Genetics) | 7 | 0.0 |
*Polymorphism, Genetic | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 9 | 0.0 |
*Chromosome Mapping | 5 | 0.0 |
*DNA-Binding Proteins | 2 | 0.0 |
Exons/genetics | 2 | 0.0 |
Genes/genetics | 2 | 5.0 |
Introns/genetics | 2 | 0.0 |
Molecular Sequence Data | 10 | 0.0 |
Phosphoprotein Phosphatase/*genetics | 2 | 5.0 |
Sequence Analysis, DNA | 3 | 0.0 |
*Transcription Factors | 2 | 0.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
*Chromosome Deletion | 6 | 0.0 |
Genes, Tumor Suppressor | 3 | 0.0 |
Heterozygote | 5 | 0.0 |
*Gene Deletion | 3 | 0.0 |
Genetic Markers/genetics | 2 | 0.0 |
Carcinoma in Situ/*genetics/pathology | 3 | 20.0 |
*Alleles | 2 | 0.0 |
Hybrid Cells | 3 | 0.0 |
Meiosis | 2 | 1.0 |
Eye Proteins/*genetics | 2 | 1.0 |
Macular Degeneration/*genetics | 2 | 4.0 |
Membrane Proteins/*genetics | 2 | 0.0 |
Child | 3 | 0.0 |
Recombination, Genetic | 3 | 0.0 |
*Mutation | 2 | 0.0 |
Blotting, Southern | 2 | 0.0 |
Cell Line | 2 | 0.0 |
Cricetulus | 2 | 0.0 |
Hamsters | 2 | 0.0 |
DNA Probes | 2 | 0.0 |
*Linkage (Genetics) | 3 | 0.0 |
Multiple Endocrine Neoplasia/*genetics | 4 | 10.0 |
Muscles/*enzymology | 2 | 2.0 |
